Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Singapore Creates Immunology Network To Coordinate Research

This article was originally published in PharmAsia News

Executive Summary

The government of Singapore has established an immunology network to tie universities, hospitals and other institutions to a system of collaboration and coordination on the core subject of the country's initiative to foster biomedical science. Eventually, the network is to help create partnerships between local and international biotech and pharmaceutical companies. Those collaborations would focus on antibody platforms, immunotherapies for cancer, and development of vaccines and diagnostic for children. The research is to be divided into three areas, cancer immunology, immune disorders and immunity to infections. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel